
About Neoaska Pharma Private Limited
Data last updated:
Neoaska Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Omnicare Drugs India Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC119969. Its GSTIN is 36AAFCN8041A1ZS (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹150 Cr and a paid-up capital of ₹23.12 Cr. It was formerly known as Neumedica Life Sciences Private Limited. It is led by directors Nagaraja Rathan Yancharla and Pakanati Venkata Raghava Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No 1 – 66/1/Ceo/1/Ph Plot No 1 Ceo Enclave, Sy No. 136/2 And 136/4 Gachibowli Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.17 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹43.01 Lakh and EBITDA of -₹4.67 Lakh (EBITDA margin -147.3%).
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹18.96 Cr on record. Court records list 12 cases involving the company, including 1 filed by the company and 11 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tatvalegal.com.
Company details
Name history
Neoaska Pharma has undergone 3 name changes throughout its history. The company was previously known as Neo Aska Pharma Private Limited, Neumedica Life Sciences Private Limited, and Omnicare Aska Pharma Private Limited. The current legal name is Neoaska Pharma Private Limited.
| Company Name | Status |
|---|---|
| Neoaska Pharma Private Limited | Current |
| Neo Aska Pharma Private Limited | Previous |
| Neumedica Life Sciences Private Limited | Previous |
| Omnicare Aska Pharma Private Limited | Previous |
Contact details
Neoaska Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDoor No 1 – 66/1/Ceo/1/Ph Plot No 1 Ceo Enclave, Sy No. 136/2 And 136/4 Gachibowli Hyderabad, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neoaska Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Neoaska Pharma Private Limited
FY 2025 filings availableNeoaska Pharma Private Limited reported revenue of ₹3.17 Lakh (down 53% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 53% in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹43.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -147.3% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neoaska Pharma Private Limited, buy the company report.
Board of directors of Neoaska Pharma Private Limited
Neoaska Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagaraja Rathan Yancharla Also directs: Ithaca Estates Private Limited, Royaume Estates Private Limited, Ardha Holding Private Limited and 5 more | Director | 13 Jul 2023 | 3 Years 3 Months | Current |
| Pakanati Venkata Raghava Reddy Also directs: Ramky - Midc Agro Processing Park Limited, Milk Lines Dairy Products Private Limited, Ramky Life Sciences Limited and 5 more | Additional Director | 01 Dec 2023 | 2 Years 11 Months | Current |
Peer comparison
Neoaska Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Soranus Lifesciences Private Limited | ₹3.26 Lakh (FY 2024) | -31.0% | Ahmedabad, Gujarat, India | |||
| Lakshmi Healthcare Products Private Limited | ₹3.25 Lakh (FY 2024) | -93.0% | Khurda, Odisha, India | |||
| Aamidex Healthcare Private Limited | ₹3.25 Lakh (FY 2025) | -72.0% | Mayur Vihar Ph, Delhi, India | |||
| Fysan Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2020) | -62.0% | Pune, Maharashtra, India | |||
| Rhone Pharmacie Private Limited | ₹3.2 Lakh (FY 2024) | 14.0% | New Delhi, Delhi, India | |||
| Neoaska Pharma Private Limitedthis company | ₹3.17 Lakh (FY 2025) | -₹43.01 Lakh | -53.0% | 30 | Hyderabad, Telangana, India | |
| Global Hemo Care Private Limited | ₹3.17 Lakh (FY 2024) | 104.0% | Parwanoo, Himachal Pradesh, India | |||
| Geion Formulations Private Limited | ₹3.16 Lakh (FY 2023) | Hyderabad, Telangana, India | ||||
| Blue Shield Healthcare (I) Private Limited | ₹3.11 Lakh (FY 2025) | -40.0% | Navi Mumbai, Maharashtra, India | |||
| Heetul Graphics Pvt Ltd | ₹3.09 Lakh (FY 2025) | -73.0% | Anand, Gujarat, India | |||
| Vitmio Pharmaceuticals Private Limited | ₹3.09 Lakh (FY 2025) | Ambarnath, Maharashtra, India |
To see the full peer comparison of Neoaska Pharma Private Limited, buy the company report.
Auditor
Neoaska Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V NARAYANA REDDY & CO | FY 2019 | 002370S |
Shareholding
The shareholding of Neoaska Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Neoaska Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Oct 2019 | 100297367 | Others | ₹18.96 Cr | Satisfied |
To see the full charge records of Neoaska Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Neoaska Pharma Private Limited has 12 court cases on record: 1 filed by Neoaska Pharma, 11 filed against it. 2 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 5 | 5 | 1 |
| NCLT | 4 | 4 | 0 |
| District courts | 2 | 2 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Afita Constructions Private Limited | Pending |
| NCLAT, Company Appeal(AT)(Ins) | Insolvency matter | Filed against the company by Afita Constructions Private Limited | Disposed |
| NCLAT, NCLAT Chennai | Insolvency matter | Filed against the company by Afita Constructions Private Limited | Disposed |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Afita Constructions Private Limited | Disposed |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Integrated Cleanroom Technologiesprivate Limited | Disposed |
To see the full case history of Neoaska Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neoaska Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neoaska Pharma Private Limited has a workforce of 30 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Neoaska Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN8041A1ZS | Telangana | Active | 13 Nov 2018 |
To see the full GST registrations and return filing status of Neoaska Pharma Private Limited, buy the company report.
Recent activity
Neoaska Pharma Private Limited has 10 board changes on record since 2020: 2 appointments and 8 cessations. The latest: Pakanati Venkata Raghava Reddy was appointed as Additional Director on 01 Dec 2023.
4 earlier events are in the company report.
Frequently asked questions
Neoaska Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2017 (9+ years old) and is registered under CIN U74999TG2017PTC119969.
Neoaska Pharma has 2 current directors:
- Nagaraja Rathan Yancharla - Director
- Pakanati Venkata Raghava Reddy - Additional Director
The latest financial statements of Neoaska Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Neoaska Pharma is 36AAFCN8041A1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Neoaska Pharma is U74999TG2017PTC119969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neoaska Pharma has 12 court cases on record: 1 filed by the company and 11 filed against it. 2 are pending. Most are in the nclat.
Neoaska Pharma was incorporated on 10 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Neoaska Pharma by revenue are Soranus Lifesciences Private Limited, Lakshmi Healthcare Products Private Limited, Aamidex Healthcare Private Limited, Fysan Pharmaceuticals Private Limited, Rhone Pharmacie Private Limited and 5 more, all in the Pharma industry (Formulations).
Pakanati Venkata Raghava Reddy was appointed as Additional Director on 01 Dec 2023. Sharan Alla ceased to be Director on 01 Dec 2023. Bavaguthu Raghuram Shetty ceased to be Director on 13 Jul 2023. Neoaska Pharma has 10 board changes on record in total.
Neoaska Pharma can be reached through the website tatvalegal.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Neoaska Pharma is at Door No 1 – 661Ceo1Ph Plot No 1 Ceo Enclave, Sy No. 1362 And 1364 Gachibowli Hyderabad, Telangana, India – 500032.

